Elanco Animal Health Says Major Technical Sections Complete For Zenrelia, With FDA Final Approval On Track For Late In Q3 Of 2024, With Final FDA Approval For Credelio Quattro Now Expected In Q4 Of 2024
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health has announced the completion of major technical sections for Zenrelia, with FDA final approval expected in late Q3 2024. Additionally, the final FDA approval for Credelio Quattro is now anticipated in Q4 2024.
June 27, 2024 | 10:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elanco Animal Health has completed major technical sections for Zenrelia, with FDA approval expected in late Q3 2024. Credelio Quattro's FDA approval is now anticipated in Q4 2024.
The completion of major technical sections and the expected FDA approvals for Zenrelia and Credelio Quattro are positive developments for Elanco Animal Health. These approvals could lead to new product launches and potential revenue growth, positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100